Variant report
Variant | esv3411330 |
---|---|
Chromosome Location | chr1:158656386-158656691 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:49)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:49 , 50 per page) page:
1
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:158656464..158659384-chr1:159045094..159048407,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SPTA1 | TF binding region |
ENSG00000163568 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565248101 | chr1:158656412-158656413 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs368830436 | chr1:158656427-158656428 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs59027997 | chr1:158656432-158656433 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs368011566 | chr1:158656433-158656434 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs550754566 | chr1:158656436-158656437 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs386368442 | chr1:158656437-158656438 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs386368443 | chr1:158656439-158656440 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs374043072 | chr1:158656442-158656443 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs34783066 | chr1:158656443-158656444 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs185621042 | chr1:158656444-158656445 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs187654461 | chr1:158656445-158656446 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs146375927 | chr1:158656454-158656455 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs569346192 | chr1:158656522-158656523 | Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs367947531 | chr1:158656530-158656531 | Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs16840548 | chr1:158656560-158656561 | Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs572110340 | chr1:158656561-158656562 | Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs139689230 | chr1:158656564-158656565 | Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs536992784 | chr1:158656574-158656575 | Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs566361869 | chr1:158656617-158656618 | Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs61403090 | chr1:158656632-158656633 | Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs200475602 | chr1:158656640-158656641 | Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs398103276 | chr1:158656641-158656642 | Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs12096998 | chr1:158656642-158656643 | Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs452233 | chr1:158656653-158656654 | Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs192303421 | chr1:158656674-158656675 | Enhancers Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Glomerulonephritis | 19341492 | CNVD |
Systemic lupus erythematosus | 18559452 | CNVD |
Systemic autoimmune disease | 17597778 | CNVD |
Glomerulonephritis | 17008540 | CNVD |
Glomerulonephritis | 16482158 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Breast cancer | 21045282 | CNVD |
Cancer | 20164920 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:158655200-158657000 | Active TSS | K562 | blood |
2 | chr1:158655800-158657000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr1:158656000-158656600 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr1:158656000-158656800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr1:158656200-158656400 | Flanking Active TSS | Primary hematopoietic stem cells short term culture | blood |
6 | chr1:158656200-158656400 | Enhancers | A549 | lung |
7 | chr1:158656200-158656600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
8 | chr1:158656200-158656800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr1:158656200-158657000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
10 | chr1:158656400-158657200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |